Immunoglobulin A Subtype and Survival After Upfront Autologous Stem Cell Transplantation in Multiple Myeloma: A Real-World Cohort from the Bortezomib Era
Simple Summary Multiple myeloma is a cancer of plasma cells, which secrete an abnormal antibody. The class of that antibody is identified in every patient during routine diagnostic work-up at no additional cost, but it plays no part in the scores used to assess disease aggressiveness. We reviewed 196 patients who recei...